Fever Of Unknown Origin
Fever of unknown origin (FUO) refers to a prolonged fever, typically lasting more than three weeks, for which a cause cannot be identified despite extensive medical evaluation. It represents a significant diagnostic challenge in medicine, encompassing a broad spectrum of potential underlying conditions that can range from infections and inflammatory diseases to malignancies and other rare disorders.
Biological Basis
Fever is a fundamental physiological response, often indicative of the body's immune system reacting to pathogens or inflammation. The biological basis of FUO is complex, as it involves the intricate interplay of immune responses, genetic predispositions, and environmental factors. Genetic variations can significantly influence an individual's susceptibility to various infections and inflammatory conditions that might manifest as fever. For instance, studies have identified the human leukocyte antigen (HLA) region as a critical determinant in host responses to infectious diseases. Specific genetic markers within this region, such as HLA-DRB1, HLA-DQB1, and HLA-B, have been associated with susceptibility or resistance to a range of infectious fevers, including enteric fever, strep throat, scarlet fever, and pneumonia. [1]
For example, the SNP rs7765379, located near HLA-DQB1 and HLA-DRB1, has shown a strong association with resistance to enteric fever, while rs6841458 near GUCY1A3 on chromosome 4 was linked to susceptibility. [1] Similarly, variants in genes like MICB and PLCE1 have been identified as susceptibility loci for specific infectious fevers such as dengue shock syndrome. [2] These genetic differences can modulate the immune system's effectiveness in combating pathogens or regulating inflammatory pathways, potentially contributing to persistent, undiagnosed fevers.
Clinical Relevance
The clinical relevance of FUO lies in the diagnostic dilemma it presents. Patients with FUO often undergo a battery of tests and consultations with various specialists in an effort to pinpoint the underlying cause. Understanding the genetic architecture of susceptibility to infectious and inflammatory conditions that cause fever could offer valuable insights, potentially guiding diagnostic investigations and leading to more targeted treatments. Genome-wide association studies (GWAS) and exome-wide genotyping are instrumental in uncovering these genetic markers, providing a foundation for future advancements in diagnosing and managing FUO. [1]
Social Importance
FUO carries substantial social importance due to its impact on patient well-being and healthcare systems. Individuals experiencing FUO often face prolonged periods of illness, anxiety, and uncertainty regarding their health, which can significantly diminish their quality of life. The extensive diagnostic workups required for FUO also impose a considerable burden on healthcare resources. Advances in understanding the genetic factors contributing to unexplained fevers hold the promise of improving diagnostic accuracy, reducing the need for invasive or redundant procedures, and ultimately leading to more effective, personalized treatment strategies.
Methodological and Statistical Constraints
Genetic studies, particularly genome-wide association studies (GWAS), are often constrained by sample size and statistical power, which can impact the reliability and generalizability of findings. Insufficient power due to smaller sample sizes can lead to a failure in replicating previous findings, as seen in studies on meningitis susceptibility where a sample of 842 cases did not replicate prior associations at CFH. [3] While some replication stages are designed to detect modest genetic effects (e.g., odds ratios > 1.5–1.6 for common variants) with high power, smaller effects or rarer variants may remain undetected, limiting the comprehensive identification of all genetic contributors. [1] Furthermore, the accuracy of imputing causal variants relies heavily on the quality and representativeness of genotyping arrays and whole-genome sequencing reference panels, which are often deficient for non-European populations, thereby reducing power and increasing the challenge of these studies. [4]
Another significant methodological limitation can arise from the statistical analysis itself, such as the omission of corrections for genomic inflation of test statistics, which can potentially lead to an overestimation of effect sizes. [5] Differences in cohort ascertainment, where some studies may be enriched for hospitalized or severe cases, can also introduce bias and contribute to variability in results across different studies. [6] This heterogeneity in study populations and analytical approaches underscores the need for careful interpretation of genetic associations and highlights the challenges in synthesizing findings from diverse research efforts.
Phenotypic Heterogeneity and Ancestry Bias
Defining disease phenotypes consistently across studies presents a considerable challenge, leading to potential heterogeneity that complicates genetic analyses. For instance, a phenotype like hepatitis B infection might encompass a broad spectrum including subclinical infections, spontaneously cleared acute infections, successfully treated cases, and chronic persistent infections, which differs significantly from studies focusing solely on chronic carriers. [3] Similarly, defining tuberculosis based on a history of positive tests may represent a different phenotype than active tuberculosis, making direct comparisons between studies difficult. [3] Such variations in phenotypic determination can obscure true genetic associations or lead to inconsistent findings.
A major limitation in genetic research is the underrepresentation of non-European populations, which results in genetic heterogeneity across different ethnic groups due to variations in allele frequency and linkage disequilibrium structure, particularly in complex regions like HLA. [3] Many studies are primarily composed of individuals with European ancestry, preventing robust multi-ancestry analyses and limiting the generalizability of findings. [7] This reliance on data from a particular ancestry hinders the discovery of novel variants prevalent in other populations and can exacerbate health disparities, as clinical applications derived from such research may not be equally effective across diverse populations. [8] Although some genetic associations for quantitative traits show directional concordance across ancestries, this consistency is often less pronounced for binary traits, possibly due to lower statistical power in diverse cohorts. [9]
Complex Etiology and Unaccounted Environmental Factors
Many diseases are complex traits influenced by a combination of genetic and environmental factors, making it challenging for genetic studies to fully capture their etiology. Disease development is rarely driven by a single gene but rather by the intricate interplay of multiple genes and environmental influences. [8] Current genetic models, even those incorporating polygenic risk scores, may not fully account for the dynamic and multifaceted nature of gene-environment interactions, leaving a gap in understanding the complete picture of disease susceptibility. [8]
Furthermore, studies may not adequately control for critical environmental confounders, which can introduce unmeasured variability and affect the observed genetic associations. Factors such as regional and temporal availability of diagnostic testing or the inability to precisely control for viral exposure among control groups can introduce heterogeneity and impact results. [6] While some studies attempt to assess gene expression in specific tissues, like the liver for ACE2 expression, the relevance of these tissues to the disease in question may not always be optimal, potentially limiting the direct applicability of findings despite shared cis-eQTLs across tissues. [6]
Variants
DSEL-AS1 is recognized as a long non-coding RNA (lncRNA), a class of RNA molecules crucial for regulating gene expression and influencing diverse cellular processes, including immune system function. The variant rs146137121 is a single nucleotide polymorphism located within or near the DSEL-AS1 gene, potentially affecting the lncRNA's stability, expression, or its ability to interact with other genes and pathways. Such alterations in DSEL-AS1's regulatory capacity could lead to dysregulated immune responses, contributing to complex conditions like fever of unknown origin (FUO), which is characterized by persistent fever without an obvious cause. Genetic variations, particularly those impacting immune regulation, are known to modulate susceptibility to various diseases and their severity. [2]
The intricate interplay of genetic factors profoundly shapes an individual's immune system, determining their response to pathogens and inflammatory stimuli. Variants in key immune genes, such as those within the Major Histocompatibility Complex (MHC) region like HLA-B and HLA-DRB1, are well-established for their associations with susceptibility to a range of infections, including strep throat, scarlet fever, and Lassa fever . [3], [4] These MHC genes are fundamental for presenting antigens to T cells, thereby orchestrating the adaptive immune response. A variant like rs146137121 in DSEL-AS1 could indirectly influence these critical immune pathways by altering the expression or function of genes involved in inflammation or immune cell activation, potentially leading to the chronic or intermittent fever seen in FUO.
The clinical implications of variants affecting non-coding RNAs like DSEL-AS1 are significant for understanding conditions like FUO, where subtle immune dysregulation can drive persistent symptoms. If DSEL-AS1 plays a role in modulating the intensity or duration of an inflammatory response, a functional variant such as rs146137121 could impair this balance, resulting in either an excessive or insufficient immune reaction. For instance, genes like CLEC16A have been linked to both autoimmune diseases and allergic phenotypes, demonstrating how genetic variations can contribute to broader immune-mediated disorders. [5] Such genetic predispositions can manifest as an inability to clear an infection efficiently, an exaggerated inflammatory response to a benign trigger, or a self-perpetuating autoimmune process, all of which are potential underlying causes of FUO. Identifying such genetic markers could offer valuable insights into the personalized diagnosis and management of patients with unexplained fevers.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs146137121 | DSEL-AS1 | fever of unknown origin |
Defining Febrile Conditions and Diagnostic Criteria
Fever is precisely defined as a physiological state characterized by a body temperature on admission greater than 37.8 degrees Celsius. [4] This serves as a fundamental diagnostic threshold for identifying a febrile condition. Beyond this general measurement approach, specific febrile illnesses possess distinct diagnostic criteria. For example, enteric fever is operationally defined and diagnosed in individuals presenting with clinical signs and symptoms, confirmed by the isolation of S. Typhi or S. Paratyphi A through culture from their blood or bone marrow. [1] Such precise definitions and diagnostic criteria are essential for consistent identification in both clinical management and research contexts.
Classification Systems and Subtypes of Fever
The classification of febrile conditions encompasses various systems and recognized subtypes. Broad nosological frameworks, such as the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), are utilized for archiving disease data and establishing medical diagnoses. [8] Within these systems, distinct febrile conditions are categorized, including enteric fever, Lassa fever, menstrual fever, and hay fever. [1] Furthermore, severity gradations are recognized, as exemplified by dengue shock syndrome, which represents a severe outcome of dengue infection [2] thereby differentiating clinical presentations and potential prognoses within a disease entity.
Terminology and Nomenclature in Febrile Illnesses
The nomenclature for febrile conditions includes both contemporary and historical terms that reflect specific characteristics and evolving medical understanding. While "fever" is a general term for elevated body temperature, more specific terms delineate particular syndromes or etiologies. For instance, "menstrual fever" describes a temperature increase that can occur during the menstrual cycle, which was historically termed "habitual hyperthermia" over seventy years ago. [10] This historical terminology illustrates how the descriptive language for physiological phenomena adapts over time. The impact of such conditions on an individual's daily life, referred to as "QOL impact by menstrual fever" [10] also forms part of the terminology used to assess the broader clinical significance of these febrile states.
Causes of Fever of Unknown Origin
Fever of unknown origin (FUO) arises from a complex interplay of genetic predispositions, environmental exposures, and various physiological factors that modulate the body's immune and inflammatory responses. While the specific etiology of FUO can be elusive, research into related febrile and inflammatory conditions provides insights into the underlying mechanisms that can contribute to its development.
Genetic Predisposition and Immune Response
Genetic factors play a significant role in an individual's susceptibility or resistance to infections and inflammatory conditions, which are common causes of fever. Inherited genetic variants, including single nucleotide polymorphisms (SNPs) and variations within immune-related gene regions, can influence how the body recognizes and responds to pathogens or triggers inflammation. For instance, strong evidence links the human leukocyte antigen (HLA) region to host genetic factors associated with specific febrile illnesses. [1] Variants in HLA-DRB1, such as the minor allele of rs7765379, have been found to be under-represented in cases of enteric fever, suggesting a role in resistance to this infectious cause of fever. [1] Another SNP, rs6841458, located near GUCY1A3 on chromosome 4, also showed a significant association with enteric fever susceptibility. [1]
Beyond specific infections, variations in the HLA class I and class II regions are associated with susceptibility to a range of common infections that can present with fever. For example, specific amino acid polymorphisms in HLA-DQB1 (Gly45) and variants in the HLA class I region (rs3131623) have been linked to scarlet fever and pneumonia susceptibility, respectively. [3] Polygenic risk, where multiple genetic variants collectively contribute to disease risk, is also a key factor, as demonstrated in genome-wide association studies (GWAS) identifying numerous loci associated with allergic diseases like asthma, hay fever, and eczema, which can involve inflammatory processes and sometimes fever. [11] These findings highlight how an individual's unique genetic makeup can predispose them to conditions that manifest as fever.
Environmental Factors and Their Genetic Interplay
Environmental factors, including exposure to pathogens, lifestyle choices, and geographic influences, are critical in triggering febrile responses, especially when interacting with an individual's genetic background. Exposure to infectious agents is a primary environmental driver of fever, with genetic variants influencing the outcome of such exposures, as seen in Lassa fever where specific human genetic variants are associated with fatal outcomes. [4] Diet and other lifestyle factors can also modulate immune function, potentially influencing the body's febrile response to various stimuli. For example, studies on food allergy have explored maternal genetic effects and parent-of-origin effects, indicating complex genetic contributions to immune responses influenced by environmental factors. [8]
Gene-environment interactions represent a crucial dimension in understanding the causes of fever. This involves how genetic predispositions are activated or modified by environmental triggers. While not directly for fever, research has identified parent-of-origin interaction effects between specific genes and environmental exposures, such as ANK3 interacting with maternal smoking or ARHGEF10 with alcohol consumption, demonstrating how inherited genetic risk can be amplified or attenuated by external factors. [12] These interactions suggest that certain environmental exposures might exacerbate a genetically predisposed inflammatory response, leading to fever, or conversely, protective genetic variants might mitigate the impact of environmental stressors.
Age-Related and Other Modifying Influences
The manifestation and duration of fever, including fever of unknown origin, can be significantly influenced by an individual's age and other physiological or medical conditions. Age-related changes in the immune system, such as immunosenescence in older adults or the developing immune system in children, can alter the febrile response to infections and inflammation. For instance, age-of-onset information has been instrumental in identifying genetic variants associated with allergic diseases, indicating that the timing of disease onset, potentially influenced by developmental stages, can have a genetic basis. [5] This suggests that genetic factors not only dictate susceptibility but also the temporal dynamics of inflammatory conditions.
While the provided context does not detail specific comorbidities or medication effects directly related to fever of unknown origin, these are generally recognized as important modulating factors in clinical practice. Existing medical conditions can alter immune responses, making individuals more prone to infections or chronic inflammation that could present as FUO. Similarly, certain medications can induce drug-related fevers or suppress typical immune responses, complicating the diagnostic process for fevers of unknown origin. Thus, age, physiological state, and concurrent health issues contribute to the complex presentation and etiology of persistent fevers.
Biological Background
Fever, an elevated body temperature, is a common physiological response, often indicating an underlying biological challenge such as infection or inflammation. When the cause of fever remains elusive, it is termed fever of unknown origin. The mechanisms underlying various forms of fever involve complex interactions across molecular, cellular, and organ systems, influenced by an individual's unique genetic makeup and environmental exposures. Understanding these biological underpinnings requires examining immune responses, signaling pathways, and the specific genetic variants that modulate them.
Immune System Modulation and Antigen Presentation
The immune system plays a central role in initiating and regulating fever, particularly through its adaptive arm, which relies on the recognition of foreign antigens. The human leukocyte antigen (HLA) complex, a highly polymorphic region, is critical for presenting antigens to T lymphocytes. For instance, specific variants within the HLA-DRB1 gene, which encodes a beta chain of HLA class II molecules, are strongly associated with resistance to enteric fever. [1] The HLA-DRB1*04:05 allele, in particular, confers significant protection against this bacterial infection, suggesting an enhanced capacity for antigen presentation and subsequent robust immune response against Salmonella Typhi or S. Paratyphi A [1] Similarly, distinct HLA alleles are implicated in susceptibility to other infectious fevers. For example, a specific amino acid polymorphism, Gly45, in the peptide-binding cleft of HLA-DQB1 is associated with scarlet fever, while variants in HLA class I (HLA-B SerTrpAsn97) and class II (HLA-DRB1 LS11) regions show independent effects on pneumonia susceptibility. [3] These genetic variations influence how effectively the immune system can detect and respond to pathogens, thereby impacting the severity and outcome of infectious fevers.
Cytokine Signaling and Inflammatory Responses
Fever is often a hallmark of systemic inflammatory responses, orchestrated by a network of signaling molecules, including cytokines. These critical proteins mediate communication between immune cells and other tissues, influencing cellular functions and regulatory networks. Genetic variations can significantly alter the production or function of these key biomolecules, thereby impacting the intensity and duration of the febrile response. For example, variants located downstream of the LIF gene, which encodes an interleukin 6 family cytokine, have been associated with fatal outcomes in Lassa fever. [4] This pleiotropic cytokine is known to protect against lung injury in viral infections and is upregulated during acute conditions like HIV infection and meningococcemia, suggesting that altered LIF regulation due to host genetic variation could profoundly affect disease severity and the body's ability to cope with the infection. [4] The intricate balance of these cytokines and their downstream signaling pathways is crucial for maintaining homeostasis and mounting an effective, yet controlled, inflammatory response.
Neuroendocrine and Receptor Pathways
Beyond direct immune activation, several fevers involve complex interactions with the nervous and endocrine systems, mediated by specific receptors and their ligands. The regulation of body temperature, a fundamental homeostatic process, can be influenced by neuroendocrine signaling. For example, menstrual fever, characterized by an increase in body temperature during the menstrual cycle, has been linked to a genetic region containing the OPRM1 gene. [10] This gene encodes the μ-opioid receptor (MOR), which binds endogenous opioids such as β-endorphin, suggesting a role for opioid signaling in modulating thermoregulation related to the menstrual cycle. [10] Additionally, the GRM7 gene, encoding metabotropic glutamate receptor 7, contains an intronic variant associated with fatal outcomes in Lassa fever. [4] While GRM7 may play a role in viral entry or immune activation, its function in maintaining inner-ear hair cells is also notable, given that hearing loss is a recognized symptom of Lassa fever, highlighting the systemic consequences that can arise from disruptions in these receptor pathways. [4]
Genetic Architecture and Regulatory Mechanisms
The diverse manifestations of fever often stem from underlying genetic mechanisms that dictate gene function, regulatory elements, and gene expression patterns. Genome-wide association studies (GWAS) have been instrumental in identifying specific genetic variants, such as single nucleotide polymorphisms (SNPs), that contribute to susceptibility or resistance to various fevers. For instance, rs7765379, located near the HLA-DQB1 and HLA-DRB1 genes, shows a strong association with enteric fever resistance, underscoring the importance of this genomic region in host defense. [1] Moreover, genetic variants can function as expression quantitative trait loci (eQTLs), influencing the expression levels of relevant protein-coding or long non-coding RNAs, thereby modulating the abundance of critical biomolecules that participate in febrile responses. The identification of specific amino acid polymorphisms within HLA loci, like HLA-DQB1 Gly45 or HLA-B SerTrpAsn97, further illustrates how subtle genetic changes can directly impact the structural and functional properties of key proteins, leading to altered immune recognition and differential disease outcomes. [3]
Immune Activation and Inflammatory Signaling
Fever of unknown origin often involves the intricate activation of immune cells and subsequent inflammatory signaling cascades. For instance, resistance to enteric fever has been associated with variation in the HLA-DRB1 gene, which plays a crucial role in antigen presentation to T cells, thus influencing the adaptive immune response. [1] Similarly, susceptibility loci for multiple common infections have been identified within the HLA region, highlighting the importance of these genes in governing immune recognition and response to pathogens. [3] Dysregulation within these pathways, potentially involving aberrant receptor activation and downstream intracellular signaling, can lead to sustained inflammatory responses that manifest as prolonged fever.
The broader context of inflammatory processes, such as those observed in allergic diseases like asthma, hay fever, and eczema, also suggests common underlying signaling pathways. While not directly "fever," these conditions involve immune cell activation and cytokine release, mediated by specific genetic variants that can influence the intensity and duration of inflammation. [11] Such inflammatory signaling involves complex molecular interactions, including receptor binding, activation of kinases, and subsequent transcription factor regulation that dictates the expression of pro-inflammatory mediators, ultimately contributing to the febrile state.
Genetic Modulators of Febrile Response
The genetic architecture underlying febrile responses and disease susceptibility plays a significant regulatory role, influencing both the initiation and resolution of fever. Genome-wide association studies (GWAS) have identified human genetic variants associated with specific febrile outcomes, such as those linked to a fatal outcome from Lassa fever. [4] These studies often pinpoint genes whose regulation, through mechanisms like eQTLs (expression quantitative trait loci) or other post-translational modifications, can alter protein function or abundance, thereby impacting the body's thermoregulatory mechanisms.
For example, genetic associations for menstrual fever have been found in regions containing the OPRM1 gene, which encodes the mu-opioid receptor (MOR). [10] The regulation of OPRM1 expression or the functional activity of its encoded receptor, potentially through gene regulation or protein modification, can modify the body's response to endogenous opioids like beta-endorphin, which are involved in thermoregulation. Such genetic predispositions underscore how subtle variations in gene regulation can lead to altered physiological responses that result in febrile episodes.
Neuroendocrine and Metabolic Regulation
The neuroendocrine system and metabolic pathways are intrinsically linked to the body's thermoregulatory processes, influencing the onset and maintenance of fever. The mu-opioid receptor (OPRM1), identified in association with menstrual fever, binds endogenous opioids and is a key component of neuroendocrine signaling that can modulate body temperature. [10] Alterations in the activity or expression of this receptor can disrupt the delicate balance of thermoregulation, leading to an elevated body temperature.
Furthermore, metabolic pathways, including those governing energy metabolism and biosynthesis, are profoundly affected during a febrile state, as maintaining an elevated temperature is an energetically demanding process. Research suggests that host factors influencing metabolic health, such as those linked to oral microbiota diversity, obesity, and type-2 diabetes, are integrated with systemic inflammatory responses. [13] This implies that dysregulation in metabolic pathways or their interplay with inflammatory signals could contribute to persistent fever.
Systems Integration and Environmental Influences
Fever often arises from a complex interplay of multiple biological systems, where pathway crosstalk and network interactions lead to emergent properties that are not predictable from individual components. The host's genetic factors influencing gut microbiome composition represent a significant area of systems integration, as the microbiome can modulate immune responses and metabolic pathways. [14] Variations in genes affecting the microbiome could indirectly contribute to systemic inflammation and febrile episodes through altered gut-derived signals.
Hierarchical regulation within the immune system, where initial recognition events cascade into broader inflammatory responses, highlights this systems-level complexity. For instance, the role of infections in autoimmune disease demonstrates how an initial trigger can lead to sustained immune activation and systemic symptoms, including fever. [15] The integrated response involves not only specific signaling pathways but also their coordination across different cell types and tissues, with environmental factors further modulating these complex networks to produce the clinical phenotype of fever.
Diagnostic Utility and Risk Stratification
Genetic analyses offer significant potential for improving the diagnostic utility and risk assessment of febrile illnesses, which can initially present as fever of unknown origin. For instance, specific genetic variants, such as those in HLA-DRB1, have been linked to resistance against particular infections like enteric fever, suggesting a genetic predisposition or protection that could guide diagnostic pathways. [1] Similarly, polygenic risk scores derived from genome-wide association studies (GWAS) can predict susceptibility and severity for various diseases, including those presenting with fever, by identifying individuals at higher risk based on their genetic makeup. [7] This genetic information could help clinicians narrow down potential etiologies and assess disease likelihood even before a definitive diagnosis is established.
The stratification of risk for severe outcomes is crucial in managing patients with fever, especially when the underlying cause is initially unclear. Research has identified genetic variants, such as those influencing ACE2 expression, that are associated with varying risks of severe disease, including ventilation or death, in infections like COVID-19, where fever is a common symptom. [6] Beyond specific genes, the presence of certain clinical symptoms at admission, like conjunctival injection or bleeding in Lassa fever, can also be correlated with age and disease progression, providing immediate indicators for risk stratification. [4] Integrating these genetic insights with clinical presentations allows for more personalized medicine approaches, enabling early identification of high-risk individuals who may require more aggressive monitoring or targeted preventative strategies.
Prognostic Indicators and Treatment Guidance
Genetic information and specific clinical markers serve as important prognostic indicators, aiding in the prediction of disease progression and outcomes for conditions that manifest with fever. For example, specific human genetic variants have been identified that are associated with fatal outcomes in severe febrile illnesses like Lassa fever, offering crucial insights into the potential trajectory of the disease. [4] Similarly, genetic risk scores (GRS), encompassing variants such as rs73064425 in LZTFL1 and others near MHC, DPP9, IFNAR2, RPL24, and FOXP4, have demonstrated associations with severe disease outcomes, including the need for ventilation or death, in infections like COVID-19. [6] These genetic insights, alongside observable clinical signs like conjunctival injection or bleeding, provide a more comprehensive picture of a patient's likely prognosis, moving beyond a simple fever diagnosis to anticipate potential complications.
The prognostic value derived from genetic and clinical data can directly inform treatment selection and the intensity of monitoring strategies. Knowing a patient's genetic predisposition to severe disease or fatal outcomes, as seen in Lassa fever, allows for the timely initiation of more aggressive therapies or enhanced supportive care. [4] For conditions like COVID-19, polygenic risk scores can identify individuals at a higher risk of severe disease, guiding clinicians to prioritize these patients for antiviral treatments, intensive care unit admission, or closer surveillance. [6] Furthermore, perturbational phenotyping of blood cells can reveal genetically determined latent traits associated with various clinical outcomes, which could eventually contribute to personalized medicine approaches by tailoring interventions based on a patient's unique genetic and physiological responses. [7]
Comorbidities and Overlapping Phenotypes
Fever, often a non-specific symptom, can be a manifestation of various underlying conditions, and genetic studies help delineate the complex relationships and overlapping phenotypes among these diseases. For example, genome-wide association studies have identified shared genetic loci influencing conditions such as asthma, hay fever, and eczema, indicating a common genetic predisposition for certain inflammatory or allergic responses that can include febrile presentations. [11] Beyond allergic diseases, genetically determined latent traits identified through perturbational phenotyping of blood cells have been associated with subsets of common diseases, suggesting that shared genetic pathways might predispose individuals to multiple conditions that could present with fever. [7] Understanding these genetic links can aid in recognizing syndromic presentations and anticipating related conditions in patients presenting with fever of unknown origin.
The genetic architecture of disease associations also sheds light on potential complications and the phenotypic heterogeneity observed in febrile illnesses. Studies using extensive electronic medical record data and diagnostic codes (ICD-9-CM, ICD-10-CM) can identify broad disease categories and their genetic underpinnings, allowing for a more comprehensive understanding of how specific infections or inflammatory states might lead to various complications. [8] Furthermore, acknowledging genetic heterogeneity across different ethnic groups and variations in how disease phenotypes are defined (e.g., acute vs. chronic infections) is critical for accurate interpretation of genetic associations and their clinical applicability. [3] This nuanced understanding supports a more holistic approach to patient care, where a fever of unknown origin might prompt consideration of a broader spectrum of genetically linked conditions and potential complications.
Frequently Asked Questions About Fever Of Unknown Origin
These questions address the most important and specific aspects of fever of unknown origin based on current genetic research.
1. My family always seems to get sick easily; am I more prone to mystery fevers?
Yes, your family's history of getting sick easily could suggest a genetic predisposition. Variations in genes, particularly in the HLA region, can influence how effectively your immune system responds to infections and inflammation. This genetic difference might make you more susceptible to prolonged, undiagnosed fevers.
2. Why do some people fight off infections fast, but my fevers drag on forever?
Your genetic makeup plays a significant role in these differences. Specific genetic markers, like those near HLA-DQB1 and HLA-DRB1, can modulate your immune system's effectiveness. This means some individuals are genetically better equipped to combat pathogens quickly, while others might experience more persistent symptoms.
3. Does my ethnic background change my risk for getting long, unexplained fevers?
Yes, your ethnic background can influence your risk. Genetic variations and their frequencies differ across populations, especially in complex regions like HLA. This means some ancestries might have distinct genetic predispositions to certain infections or inflammatory conditions that can cause fever of unknown origin.
4. Could a special DNA test help find out why my fever won't go away?
Potentially, yes. Advanced genetic studies are identifying specific genetic markers linked to susceptibility to various fevers. Understanding your genetic profile could offer valuable insights, helping doctors guide diagnostic investigations and potentially lead to more targeted treatments for your prolonged fever.
5. If I get these long fevers, can doctors use my genes to treat me better?
That's a major promise of genetics research. By understanding your specific genetic variations that influence immune responses, doctors hope to develop more personalized treatment strategies. This could mean more effective therapies tailored to your unique genetic susceptibility, reducing the need for trial-and-error.
6. My sibling rarely gets sick, but I always do; why the difference in fevers?
Even within families, individual genetic variations can lead to different immune responses. You and your sibling might have different genetic markers, for instance in the HLA region, that influence how well your bodies detect and fight off infections or regulate inflammation, explaining your differing susceptibility to fevers.
7. Is it true that some people's immune systems are just "wired" differently for fevers?
Yes, absolutely. Your immune system's "wiring" is heavily influenced by your genetics. Specific genetic variants can make your immune system respond more or less effectively to pathogens or inflammation, contributing to why some people experience persistent, unexplained fevers.
8. Why does my body keep getting these long, unexplained fevers?
Your genetic makeup can significantly influence how your body responds to infections or inflammation, which might be why you experience persistent, unexplained fevers. Variations in genes, particularly in the HLA region, can modulate your immune system's effectiveness, making it harder to pinpoint the exact cause.
9. Can understanding my genes help prevent future mystery fevers?
While not a direct prevention for every fever, understanding your genetic predispositions can be very insightful. It could help identify if you're at higher risk for certain types of infectious or inflammatory conditions, potentially guiding lifestyle choices or early interventions to manage your susceptibility.
10. Why is it so hard for doctors to find out what's causing my long fever?
It's incredibly challenging because prolonged fevers often involve a complex interplay of your immune system, genetic predispositions, and environmental factors. Many underlying conditions can present as fever, and genetic variations make the diagnostic puzzle even more intricate for doctors to solve.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Dunstan, S. J., et al. "Variation at HLA-DRB1 is associated with resistance to enteric fever." Nat Genet, vol. 47, no. 1, 2015, pp. 13-16.
[2] Khor, C. C. et al. "Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1." Nat Genet, 2011.
[3] Tian, C. et al. "Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections." Nat Commun, 2017.
[4] Kotliar, D. et al. "Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever." Nat Microbiol, 2024.
[5] Ferreira, Manuel A., et al. "Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype." Journal of Allergy and Clinical Immunology, vol. 133, no. 6, June 2014, pp. 1564-1572.
[6] Horowitz, J. E., et al. "Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease." Nat Genet, vol. 54, no. 4, 2022, pp. 446-455. PMID: 35241825.
[7] Homilius, M., et al. "Perturbational phenotyping of human blood cells reveals genetically determined latent traits associated with subsets of common diseases." Nat Genet, vol. 55, no. 12, 2023, pp. 2095-2108. PMID: 38049662.
[8] Liu, T. Y., et al. "Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population." Sci Adv, vol. 10, no. 20, 2024, eadn1005.
[9] Backman, Joshua D., et al. "Exome sequencing and analysis of 454,787 UK Biobank participants." Nature, vol. 599, 25 Nov. 2021, pp. 631-636.
[10] Hirata, T., et al. "Japanese GWAS identifies variants for bust-size, dysmenorrhea, and menstrual fever that are eQTLs for relevant protein-coding or long non-coding RNAs." Sci Rep, vol. 8, no. 1, 2018, p. 8411.
[11] Johansson, A., et al. "Genome-wide association analysis of 350 000 Caucasians from the UK Biobank identifies novel loci for asthma, hay fever and eczema." Hum Mol Genet, vol. 28, no. 16, 2019, pp. 2786-2795.
[12] Haaland, Odd André, et al. "A genome-wide scan of cleft lip triads identifies parent-of-origin interaction effects between ANK3 and maternal smoking, and between ARHGEF10 and alcohol consumption." F1000Research, 2019.
[13] Stankevic, E., et al. "Genome-wide association study identifies host genetic variants influencing oral microbiota diversity and metabolic health." Sci Rep, vol. 14, no. 1, 2024, p. 14457.
[14] Kurilshikov, A., et al. "Large-scale association analyses identify host factors influencing human gut microbiome composition." Nat Genet, vol. 53, no. 2, 2021, pp. 156–165.
[15] Ercolini, A. M., and S. D. Miller. "The role of infections in autoimmune disease." Clin. Exp. Immunol., vol. 155, no. 1, 2009, pp. 1–15.